These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11217545)

  • 21. High-intensity focused ultrasound for prostate cancer: comparative definitions of biochemical failure.
    Blana A; Brown SC; Chaussy C; Conti GN; Eastham JA; Ganzer R; Murat FJ; Pasticier G; Rebillard X; Rewcastle JC; Robertson CN; Thuroff S; Ward JF
    BJU Int; 2009 Oct; 104(8):1058-62. PubMed ID: 19388986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of prostatic cancer with high intensity focused ultrasound (HIFU) using Ablatherm device].
    Aliaev IuG; Krupinov GE; Bezrukov EA; Grigorian VA; Amosov AV; Chalyĭ ME; Kobzev DN; Bruk IuF; Shestiperov PA
    Urologiia; 2007; (6):39-44. PubMed ID: 18649659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential ultrasonic imaging for the characterization of lesions induced by high intensity focused ultrasound.
    Zhong H; Wan M; Jiang Y; Wang S
    Ultrasonics; 2006 Dec; 44 Suppl 1():e285-8. PubMed ID: 16844167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extracorporeal high intensity focused ultrasound ablation in the treatment of 1038 patients with solid carcinomas in China: an overview.
    Wu F; Wang ZB; Chen WZ; Wang W; Gui Y; Zhang M; Zheng G; Zhou Y; Xu G; Li M; Zhang C; Ye H; Feng R
    Ultrason Sonochem; 2004 May; 11(3-4):149-54. PubMed ID: 15081972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluorescence imaging for real-time monitoring of high-intensity focused ultrasound cardiac ablation.
    Deng CX; Qu F; Nikolski VP; Zhou Y; Efimov IR
    Ann Biomed Eng; 2005 Oct; 33(10):1352-9. PubMed ID: 16240084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Transurethral resection of prostate just following high intensity focused ultrasound in localized prostate cancer--trial for early removal of the urethral catheter].
    Otsuki H; Sumitomo M; Umeda S; Shirotake S; Tobe M; Ito K; Asano T; Nagakura K; Hayakawa M
    Hinyokika Kiyo; 2008 Mar; 54(3):189-95. PubMed ID: 18411774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIFU and cryoablation--non or minimal touch techniques for the treatment of prostate cancer. Is there a role for contrast enhanced ultrasound?
    Wondergem N; De La Rosette JJ
    Minim Invasive Ther Allied Technol; 2007; 16(1):22-30. PubMed ID: 17365674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-energy shockwaves and extracorporeal high-intensity focused ultrasound.
    Madersbacher S; Marberger M
    J Endourol; 2003 Oct; 17(8):667-72. PubMed ID: 14622487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors predicting for formation of bladder outlet obstruction after high-intensity focused ultrasound in treatment of localized prostate cancer.
    Blana A; Hierl J; Rogenhofer S; Lunz JC; Wieland WF; Walter B; Bach T; Ganzer R
    Urology; 2008 May; 71(5):863-7. PubMed ID: 18313119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current status of HIFU and cryotherapy in prostate cancer--a review.
    Aus G
    Eur Urol; 2006 Nov; 50(5):927-34; discussion 934. PubMed ID: 16971038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High intensity ultrasound.
    ter Haar G
    Semin Laparosc Surg; 2001 Mar; 8(1):77-89. PubMed ID: 11337740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. To what extent does the prostate-specific antigen nadir predict subsequent treatment failure after transrectal high-intensity focused ultrasound therapy for presumed localized adenocarcinoma of the prostate?
    Uchida T; Illing RO; Cathcart PJ; Emberton M
    BJU Int; 2006 Sep; 98(3):537-9. PubMed ID: 16925749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anaesthesia for high intensity focused ultrasound (HIFU) therapy.
    Yao CL; Trinh T; Wong GT; Irwin MG
    Anaesthesia; 2008 Aug; 63(8):865-72. PubMed ID: 18699899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elastography for the follow-up of high-intensity focused ultrasound prostate cancer treatment: initial comparison with MRI.
    Curiel L; Souchon R; Rouvière O; Gelet A; Chapelon JY
    Ultrasound Med Biol; 2005 Nov; 31(11):1461-8. PubMed ID: 16286025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of neoadjuvant androgen suppression on prostate cancer-related outcomes after high-intensity focused ultrasound therapy.
    Uchida T; Illing RO; Cathcart PJ; Emberton M
    BJU Int; 2006 Oct; 98(4):770-2. PubMed ID: 16879448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular MR imaging and MR-guided ultrasound therapies in cancer.
    Grenier N; Quesson B; de Senneville BD; Trillaud H; Couillaud F; Moonen C
    JBR-BTR; 2009; 92(1):8-12. PubMed ID: 19358479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transrectal high-intensity focused ultrasound ablation of prostate cancer: effective treatment requiring accurate imaging.
    Rouvière O; Souchon R; Salomir R; Gelet A; Chapelon JY; Lyonnet D
    Eur J Radiol; 2007 Sep; 63(3):317-27. PubMed ID: 17689218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Focal therapy with high-intensity-focused ultrasound in the treatment of localized prostate cancer.
    Muto S; Yoshii T; Saito K; Kamiyama Y; Ide H; Horie S
    Jpn J Clin Oncol; 2008 Mar; 38(3):192-9. PubMed ID: 18281309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high-intensity focused ultrasound.
    Cirillo S; Petracchini M; D'Urso L; Dellamonica P; Illing R; Regge D; Muto G
    BJU Int; 2008 Aug; 102(4):452-8. PubMed ID: 18476973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Results of transrectal focused ultrasound for the treatment of localized prostate cancer (120 patients with PSA < or + 10ng/ml].
    Poissonnier L; Gelet A; Chapelon JY; Bouvier R; Rouviere O; Pangaud C; Lyonnet D; Dubernard JM
    Prog Urol; 2003 Feb; 13(1):60-72. PubMed ID: 12703356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.